516 related articles for article (PubMed ID: 7528680)
1. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
[TBL] [Abstract][Full Text] [Related]
3. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
4. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
Becker J; Li Z; Noe CR
Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
[TBL] [Abstract][Full Text] [Related]
5. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
6. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
7. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors.
Honer M; Benke D; Laube B; Kuhse J; Heckendorn R; Allgeier H; Angst C; Monyer H; Seeburg PH; Betz H; Mohler H
J Biol Chem; 1998 May; 273(18):11158-63. PubMed ID: 9556603
[TBL] [Abstract][Full Text] [Related]
10. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
Sharma TA; Reynolds IJ
J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
[TBL] [Abstract][Full Text] [Related]
12. Support for radiolabeling of a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex by 5,7-[3H]dichlorokynurenate in rat brain.
Yoneda Y; Suzuki T; Ogita K; Han D
J Neurochem; 1993 Feb; 60(2):634-45. PubMed ID: 8419541
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of the molecular interaction between PSD-95 and NMDA receptors: the effect of the NR1 splice variant and evidence for modulation of channel gating.
Rutter AR; Freeman FM; Stephenson FA
J Neurochem; 2002 Jun; 81(6):1298-307. PubMed ID: 12068077
[TBL] [Abstract][Full Text] [Related]
15. Molecular distinction of three N-methyl-D-aspartate-receptor subtypes in situ and developmental receptor maturation demonstrated with the photoaffinity ligand 125I-labeled CGP 55802A.
Marti T; Benke D; Mertens S; Heckendorn R; Pozza M; Allgeier H; Angst C; Laurie D; Seeburg P; Mohler H
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8434-8. PubMed ID: 8378316
[TBL] [Abstract][Full Text] [Related]
16. High level expression of the NMDAR1 glutamate receptor subunit in electroporated COS cells.
Ishmael JE; Franklin PH; Murray TF; Leid M
J Neurochem; 1996 Oct; 67(4):1500-10. PubMed ID: 8858933
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
18. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
19. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
